Company: DMAAR
Filing Date: 2025-11-18
Form Type: 10-Q
Source: 0001213900-25-112096
Chunk: 112

Company: Drugs Made In America Acquisition Corp.
Filing Date: 2025-11-18
Form: 10-Q
Item: Part I, Item 2
Chunk 112
---
 the earliest to occur of: (1) our completion of an initial business combination; (2) the redemption of any public
shares properly submitted in connection with a shareholder vote to amend our amended and restated memorandum and articles of association
(A) to modify the substance or timing of our obligation to allow redemption in connection with our initial business combination or to
redeem 100% of our public shares if we do not complete our initial business combination within the completion window or (B) with respect
to any other material provisions relating to shareholders’ rights or pre-initial business combination activity; and (3) the redemption
of our public shares if we have not completed an initial business combination within the completion window, subject to applicable law.
The funds in the trust account will be invested only in U.S. government treasury obligations with a maturity of 185 days or less or in
money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government
treasury obligations and/or held as cash or cash items (including in demand deposit accounts).

We
will have up to 15 months to consummate an initial business combination (April 29, 2026) from the closing of the IPO (which may be extended
without shareholder approval up to two times, each by an additional three months (for a total of up to 21 months to complete an initial
business combination from the closing of the IPO), subject to the sponsor depositing into the trust account $0.10 per public share outstanding
in connection with each such extension). If we are unable to consummate an initial business combination within such time period, we will
redeem 100% of the issued and outstanding public shares for a pro rata portion of the funds held in the trust account, equal to the aggregate
amount then on deposit in the trust account, including interest earned on the funds held in the trust account (net of funds withdrawn
to pay our taxes, if any, and up to $100,000 of interest to pay dissolution expenses), divided by the number of then issued and outstanding
public shares, subject to applicable law, and then seek to liquidate and subsequently dissolve.

20

We
will provide our public shareholders with the opportunity to redeem all or a portion of their public shares upon the completion of our
initial business combination at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account
calculated as of two business days